India–EU FTA eases market access, cuts tariffs for Indian pharma and medical devices
Europe remains a large but under-penetrated destination for Indian drugmakers. Data from the Pharmaceuticals Export Promotion Council of India (Pharmexcil) show that the EU accounts for about 19% of India’s pharmaceutical exports, despite India being a leading global supplier of generic medicines.
Europe remains a large but under-penetrated destination for Indian drugmakers. Data from the Pharmaceuticals Export Promotion Council of India (Pharmexcil) show that the EU accounts for about 19% of India’s pharmaceutical exports, despite India being a leading global supplier of generic medicines.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
